QUANTIFYING PRODUCTIVITY FOR A GENERIC PHARMACEUTICAL COMPANY
Divya Chauhan1, Dr. Nusrat Khan2
1Research Scholar- School of Business Management at Noida International University, Noida & Project Manager at Fresenius Kabi Oncology Ltd., Gurgaon
2Associate Professor –School of Business Management at Noida International University, Noida.
ABSTRACT
Productivity is critical for the long-term competitiveness and
profitability of organisations. It is considered as the best tool for
comparing management effectiveness between different units of an
enterprise as well as between different enterprises. It provides
information on how effectively and efficiently an organisation
manages its resources. Paul J. Meyer’s quoted this as “Productivity is
never an accident. It is always the result of a commitment to
excellence, intelligent planning, and focused effort.” But the question
is how to quantify ‘Productivity’? Conventional measures of
productivity are based on output per unit time and are getting obsolete
now. In current scenario, various other measures are used for
productivity. For a Generic Pharmaceutical company, productivity is
analyzed by number of factors like volume of products reaching the
market, knowledge input in terms of number of Patents filed, number
of drug candidates completing a successful phase of clinical development and many more.
This paper focuses on some of such factors which play an important role in assessing the
productivity of a Generic Pharmaceutical Company.
Keywords: Productivity, Patents, Clinical development, Generic Pharmaceutical Company.
[Download Article]
[Download Certifiate]